# The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects

> **NCT02516436** · PHASE3 · WITHDRAWN · sponsor: **BioDelivery Sciences International**

## Conditions studied

- Opioid Dependence

## Interventions

- **DRUG:** BEMA Buprenorphine NX
- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT02516436
- **Lead sponsor:** BioDelivery Sciences International
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2017-05-01
- **Final completion:** 2017-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** FDA did not require a clinical trial for indication.
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02516436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02516436, "The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02516436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*